<DOC>
	<DOCNO>NCT03035474</DOCNO>
	<brief_summary>CONNECT-HF large-scale , pragmatic , cluster-randomized clinical trial evaluate effect 2 quality improvement ( QI ) initiative compare usual care heart failure ( HF ) outcomes HF quality care metric 1 year discharge participant hospitalize acute HF reduce ejection fraction ( EF ) . The intervention include health-system engagement group ( direct ) participant engagement group ( digital ) .</brief_summary>
	<brief_title>Care Optimization Through Patient Hospital Engagement Clinical Trial Heart Failure</brief_title>
	<detailed_description>CONNECT-HF large-scale , pragmatic , cluster-randomized clinical trial evaluate effect 2 quality improvement ( QI ) initiative compare usual care heart failure ( HF ) outcomes HF quality care metric 1 year discharge participant hospitalize acute HF reduce ejection fraction ( EF ) . All participant trial consent longitudinal follow-up part CONNECT-HF registry clinical outcome , medication use , participant-centered outcome , include quality life ( QOL ) assessment , 6 week 3 , 6 , 12 month discharge . Two QI initiative evaluate trial : A health-system engagement strategy ( direct ) involve site visit ongoing mentor team healthcare professional specialize training field experience help health system individual hospital design local quality improvement plan . A participant engagement strategy ( digital ) mobile application utilizing behavioral tool reinforce health behavior , include self-monitoring/self-management medication adherence . After index hospitalization HF , longitudinal information management ( ie , HF medication ) , QOL assessment , resource utilization collect . Follow-up occur via centralized telephone interview train personnel via DCRI Call Center . At interview , participant ask report current medication , rehospitalizations , QOL assessment . Based participant-reported event , medical billing data rehospitalizations , emergency department visit , procedure obtain . Quality life assessment include Kansas City Cardiomyopathy Questionnaire ( KCCQ ) EuroQOL five dimension questionnaire ( EQ-5D ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Provide inform consent trial enrollment Age ≥ 18 year Acute HF primary cause hospitalization previous clinical diagnosis HF Hospitalizations acute HF determine local clinicianinvestigators include follow : Symptoms ( eg , dyspnea , fatigue ) , sign ( eg , elevate jugular venous pressure , peripheral edema ) , laboratory/imaging evidence HF ( eg , pulmonary congestion chest xray , elevate natriuretic peptide level ) hospitalization Treatments aim acute HF ( eg , intravenous diuretic , vasodilator , inotropes ) LVEF ≤ 40 % base last local measurement use echocardiography , multigated acquisition scan , compute tomography ( CT ) scanning , magnetic resonance imaging , ventricular angiography Planned discharge home support care facility patient individually responsible medication management Prior heart transplant current/planned leave ventricular assistance device Chronic kidney disease require dialysis Terminal illness HF , malignancy , life expectancy le 1 year determine enrol clinicianinvestigator Unable use mobile application participate longitudinal followup , plan move outside US follow year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Quality Improvement</keyword>
</DOC>